Association Between Stroke and Adrenal Incidentalomas
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorXuanwu Hospital, Beijing
About this trial
Adrenal incidentalomas (AIs) are commonly encountered in transsection imaging which purpose not for suspected adrenal disease. However, part of AIs in patients is associated with Stroke. Stroke is a diseases which could cause of disability and death worldwide. In clinical practice, detailed information about the association between stroke and AIs is not available. In this study, the investigators aimed to investigate the risk for disability and death in the large group of stroke patients with AIs.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
stroke disease , such as Cerebral infarction、Intracerebral hemorrhage and Subarachnoid hemorrhage.
Disqualifiers
presence of metastatic cancer;
AIs smaller than 1 cm;
nonadenoma lesions, such as myelolipomas,hemorrhages, and cysts;
oral glucocorticoid treatment with more than single doses in the past 3 months;
Trial population
Patients with Stroke disease, and erolled in our emergency or clinical department.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
2 Participants
are grouped into 3 trial groupsGroup A: Cerebral infarction Group
Group B: Intracerebral hemorrhage Group
Group C: Subarachnoid hemorrhage Group
Trial outcomes
Primary outcomes
1
Incidence rate of Adrenal incidentalomas
Assess the standardised incidence rate of AIs in all patients with stroke
Time frame
5 years2
Plasma cortisol level
Plasma cortisol level after a 1-mg dexamethasone suppression test
Time frame
5 yearsSecondary outcomes
1
Diameter of Adrenal incidentalomas
Maximal axial diameter of adrenal incidentalomas by computed tomography scan; Millimetre as a metric unit of length in this study
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov